These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 34313784)
81. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells. Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137 [TBL] [Abstract][Full Text] [Related]
82. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein. Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160 [No Abstract] [Full Text] [Related]
83. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport. Shirasaka Y; Kawasaki M; Sakane T; Omatsu H; Moriya Y; Nakamura T; Sakaeda T; Okumura K; Langguth P; Yamashita S Drug Metab Pharmacokinet; 2006 Oct; 21(5):414-23. PubMed ID: 17072095 [TBL] [Abstract][Full Text] [Related]
84. Ezrin and radixin both regulate the apical membrane localization of ABCC2 (MRP2) in human intestinal epithelial Caco-2 cells. Yang Q; Onuki R; Nakai C; Sugiyama Y Exp Cell Res; 2007 Oct; 313(16):3517-25. PubMed ID: 17825285 [TBL] [Abstract][Full Text] [Related]
85. Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia. Morales FC; Takahashi Y; Kreimann EL; Georgescu MM Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17705-10. PubMed ID: 15591354 [TBL] [Abstract][Full Text] [Related]
86. Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells. Duan Z; Brakora KA; Seiden MV Mol Cancer Ther; 2004 Jul; 3(7):833-8. PubMed ID: 15252144 [TBL] [Abstract][Full Text] [Related]
87. Blockage of drug resistance in vitro by disulfiram, a drug used to treat alcoholism. Loo TW; Clarke DM J Natl Cancer Inst; 2000 Jun; 92(11):898-902. PubMed ID: 10841824 [TBL] [Abstract][Full Text] [Related]
88. Establishment of a P-glycoprotein substrate screening model and its preliminary application. Wang Y; Cao J; Zeng S World J Gastroenterol; 2004 May; 10(9):1365-8. PubMed ID: 15112361 [TBL] [Abstract][Full Text] [Related]
89. Anticancer Profiling for Coumarins and Related Baghdadi MA; Al-Abbasi FA; El-Halawany AM; Aseeri AH; Al-Abd AM Molecules; 2018 Apr; 23(5):. PubMed ID: 29701706 [TBL] [Abstract][Full Text] [Related]
90. Time-dependent changes in the activation of RhoA/ROCK and ERM/p-ERM in the increased expression of intestinal P-glycoprotein by repeated oral treatment with etoposide. Kobori T; Harada S; Nakamoto K; Tokuyama S J Pharm Sci; 2013 May; 102(5):1670-82. PubMed ID: 23508810 [TBL] [Abstract][Full Text] [Related]
91. [SIRT1 participates in epithelial-mesenchymal transition of EC-9706 and Eca-109 cells Wu Y; Xin D; Liu C; Wang F Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1325-1330. PubMed ID: 30514680 [TBL] [Abstract][Full Text] [Related]
92. Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells. Dong J; Zhai B; Sun W; Hu F; Cheng H; Xu J PLoS One; 2017; 12(9):e0185088. PubMed ID: 28934275 [TBL] [Abstract][Full Text] [Related]
93. Effects of the chemosensitizer verapamil on P-glycoprotein substrate efflux in rainbow trout hepatocytes. Johnston CU; Kennedy CJ Comp Biochem Physiol C Toxicol Pharmacol; 2024 Jan; 275():109763. PubMed ID: 37820937 [TBL] [Abstract][Full Text] [Related]
94. SNAI1 interacts with HDAC1 to control TGF‑β2‑induced epithelial‑mesenchymal transition in human lens epithelial cells. Gao N; Li J; Qin Y; Wang Y; Kang Q; Pei C Int J Mol Med; 2020 Jan; 45(1):265-273. PubMed ID: 31746377 [TBL] [Abstract][Full Text] [Related]
95. Simotinib as a modulator of P-glycoprotein: substrate, inhibitor, or inducer? Huang L; Shen C; Chen Y; Yan H; Cheng Z; Zhu Q Anticancer Drugs; 2016 Apr; 27(4):300-11. PubMed ID: 26766493 [TBL] [Abstract][Full Text] [Related]
96. Reversal of multi-drug resistance by vector-based-shRNA-mdr1 in vitro and in vivo. Lu S; Huang Q; Wang Z; Song Y; Wang L J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):620-4. PubMed ID: 19821097 [TBL] [Abstract][Full Text] [Related]
97. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. Binkhathlan Z; Lavasanifar A Curr Cancer Drug Targets; 2013 Mar; 13(3):326-46. PubMed ID: 23369096 [TBL] [Abstract][Full Text] [Related]
98. Mutant p53 promotes RCP-dependent chemoresistance coinciding with increased delivery of P-glycoprotein to the plasma membrane. Phatak V; von Grabowiecki Y; Janus J; Officer L; Behan C; Aschauer L; Pinon L; Mackay H; Zanivan S; Norman JC; Kelly M; Le Quesne J; Muller PAJ Cell Death Dis; 2021 Feb; 12(2):207. PubMed ID: 33627632 [TBL] [Abstract][Full Text] [Related]
99. Epigenetic Regulation and Post-Translational Modifications of SNAI1 in Cancer Metastasis. Dong B; Wu Y Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681726 [TBL] [Abstract][Full Text] [Related]
100. The functional influences of common ABCB1 genetic variants on the inhibition of P-glycoprotein by Antrodia cinnamomea extracts. Sheu MJ; Teng YN; Chen YY; Hung CC PLoS One; 2014; 9(2):e89622. PubMed ID: 24586917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]